Beijing Tongkanghui Network Technology Co., Ltd announced that it has received CNY 99.968 million in funding from Guangdong Temei Health Technology Industry Co., Ltd., Teyi Pharmaceutical Group Co.,Ltd
November 01, 2021
Share
Beijing Tongkanghui Network Technology Co., Ltd announced that it has received $15,600,000 (CNY 99,968,000) in a equity round of funding from Guangdong Temei Health Technology Industry Co., Ltd. and returning investor Teyi Pharmaceutical Group Co.,Ltd and on November 2, 2021. The actual investment amount of Guangdong Temei Health Technology Industry Co., Ltd. and the allocation ratio of the capital increase will be subject to the investment agreement officially signed by the company. The estimated pre-money valuation is of approximately CNY 550 million.
TEYI PHARMACEUTICAL GROUP CO., LTD, formerly Guangdong Taicheng Pharmaceutical Co., Ltd., is principally engaged in the production and sale of pharmaceuticals. The Company primarily provides Chinese traditional patent medicines, including cough arresting and phlegm removing medicine series, kidney reinforcing medicine series and anti-infection medicine series, among others. The Company's products mainly include tablets, granules, medicinal tea, syrup, decocted extracts, capsules, powder, ointment, cream, as well as oral solutions, among others.
Beijing Tongkanghui Network Technology Co., Ltd announced that it has received CNY 99.968 million in funding from Guangdong Temei Health Technology Industry Co., Ltd., Teyi Pharmaceutical Group Co.,Ltd